NCT00004040View on ClinicalTrials.gov

Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After Chemotherapy

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 1998

Primary Completion Date

June 30, 1999

Study Completion Date

June 30, 1999

Conditions
LeukemiaMultiple Myeloma and Plasma Cell Neoplasm
Interventions
BIOLOGICAL

recombinant interferon alfa

BIOLOGICAL

rituximab

Trial Locations (3)

37901

Baptist Regional Cancer Center - Knoxville, Knoxville

77802

St. Joseph Regional Cancer Center, Bryan

92658

Hoag Memorial Hospital Presbyterian, Newport Beach

Sponsors
All Listed Sponsors
collaborator

Cancer Biotherapy Research Group

OTHER

lead

Hoag Memorial Hospital Presbyterian

OTHER

NCT00004040 - Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After Chemotherapy | Biotech Hunter | Biotech Hunter